Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells in Drug Discovery 2016

Herbert Mueller-Hartmann's Biography



Herbert Mueller-Hartmann, Head of Global Technology Development, Lonza Bioscience

Herbert received his professional education in molecular and cellular biology at Universities of Munich and Cologne working on protein design and function linked to human disease. In 2000 he moved into industry joining amaxa biosystems doing technology development fusing molecular biology and engineering sciences and help bringing amaxa’s first product line to the market, Nucleofector™ technology. In the last one and a half decade Herbert led several R&D teams in Europe and the U.S. developing technologies and products for the QC testing, biomanufacturing, and research markets, among others for high-performance cell modification, analysis and their use in biological screening.

Herbert Mueller-Hartmann Image

Using Pluripotent Stem Cells in the Age of Genome Editing

Tuesday, 5 April 2016 at 12:15

Add to Calendar ▼2016-04-05 12:15:002016-04-05 13:15:00Europe/LondonUsing Pluripotent Stem Cells in the Age of Genome EditingStem Cells in Drug Discovery 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

The advantages of different cellular models for cell-based assays will be discussed. Among other developments, the use of induced pluripotent stem cells (iPSCs) has opened up new possibilities, including new types of disease modeling.


Add to Calendar ▼2016-04-05 00:00:002016-04-06 00:00:00Europe/LondonStem Cells in Drug Discovery 2016Stem Cells in Drug Discovery 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com